Cedrik Michael Britten

Summary

Country: Germany

Publications

  1. ncbi request reprint Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005
    C M Britten
    III Medical Department, University of Mainz, Langenbeckstr 1, 55131, Mainz, Germany
    Cancer Immunol Immunother 55:475-80. 2006
  2. pmc Toward the harmonization of immune monitoring in clinical trials: quo vadis?
    C M Britten
    Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    Cancer Immunol Immunother 57:285-8. 2008
  3. pmc The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
    C M Britten
    Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    Cancer Immunol Immunother 57:289-302. 2008
  4. pmc Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
    Cedrik Michael Britten
    Tumor Immunology Group, Department for Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
    Cancer Immunol Immunother 58:1701-13. 2009
  5. pmc Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
    C M Britten
    III Medical Department, Johannes Gutenberg University, Mainz, Germany
    Cancer Immunol Immunother 60:15-22. 2011
  6. ncbi request reprint Cancer Immunotherapy 2004: Mainz, Germany, 6-7 may 2004
    C M Britten
    III Medical Department, University of Mainz, Langenbeckstr 1, 55131 Mainz, Germany
    Cancer Immunol Immunother 53:1153-8. 2004
  7. ncbi request reprint CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006
    C Gouttefangeas
    Department of Immunology, Institute for Cell Biology, University of Tubingen, Auf der Morgenstelle 15, 72076 Tubingen, Germany
    Cancer Immunol Immunother 56:397-427. 2007

Detail Information

Publications7

  1. ncbi request reprint Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005
    C M Britten
    III Medical Department, University of Mainz, Langenbeckstr 1, 55131, Mainz, Germany
    Cancer Immunol Immunother 55:475-80. 2006
    ..The lectures selected for this report aim to provide an overview of the complete scientific program and give an impression of the lively atmosphere that could be felt from the first until the last session of CIMT 2005...
  2. pmc Toward the harmonization of immune monitoring in clinical trials: quo vadis?
    C M Britten
    Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    Cancer Immunol Immunother 57:285-8. 2008
  3. pmc The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
    C M Britten
    Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    Cancer Immunol Immunother 57:289-302. 2008
    ..Such "two-step" inter-laboratory projects could define rational bases for accepted international guidelines and thereby lead to the harmonization of the techniques used for immune monitoring...
  4. pmc Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
    Cedrik Michael Britten
    Tumor Immunology Group, Department for Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
    Cancer Immunol Immunother 58:1701-13. 2009
    ..The Cancer Vaccine Consortium of the Cancer Research Institute (CVC-CRI) conducted a multicenter HLA-peptide multimer proficiency panel (MPP) with a group of 27 laboratories to assess the performance of the assay...
  5. pmc Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
    C M Britten
    III Medical Department, Johannes Gutenberg University, Mainz, Germany
    Cancer Immunol Immunother 60:15-22. 2011
    ..An additional objective of this undertaking is to engage the broader scientific community to comment on MIATA and to become an active participant in the project...
  6. ncbi request reprint Cancer Immunotherapy 2004: Mainz, Germany, 6-7 may 2004
    C M Britten
    III Medical Department, University of Mainz, Langenbeckstr 1, 55131 Mainz, Germany
    Cancer Immunol Immunother 53:1153-8. 2004
  7. ncbi request reprint CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006
    C Gouttefangeas
    Department of Immunology, Institute for Cell Biology, University of Tubingen, Auf der Morgenstelle 15, 72076 Tubingen, Germany
    Cancer Immunol Immunother 56:397-427. 2007